RxDoctor Payments Data

Zachary Strumpf, MD

Hospitalist · Cleveland, OHNPI 1891158374

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Noctrix Health, Inc. accounts for 80.1% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $1,467, more than ten times the $121 reported in 2022. Among hospitalist clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,812in general payments, 2019–2025

Across 22 payments — averaging $82.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Noctrix Health, Inc.$1K
  • AstraZeneca$70
  • Boehringer Ingelheim$66
  • Merck$47
  • Jazz Pharmaceuticals Inc.$40
  • Mylan Specialty L.p.$31
  • plus $106 from 6 others

What the payments were for

  • Food & beverage$1,812100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,812 in reported general payments places this provider in the 95th percentile of 813 hospitalist providers in Ohio.

See all hospitalist providers in Ohio

Medicare billing

Part B allowed, 2024
$18,095
Medicare patients
105
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,746
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$7,156
Spiriva RespimatTiotropium Bromide13$7,005
Albuterol Sulfate HfaAlbuterol Sulfate17$578
Fluticasone Propionate17$116
Prednisone11$48

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimSpiriva Respimat$66$7,00513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 813 hospitalist providers in Ohio.

Other hospitalist in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →